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Abstract
Background: Paraben exposure occurs everyday to most people unknowingly. Parabens are
present in most personal care products in varying amounts. Presently, parabens are not listed as
endocrine disruptors; however, some research has shown parabens associated with decreases in
thyroid hormone levels. The chemical and adsorption mechanism for parabens in association with
thyroid hormones is not well understood. Determining whether parabens are associated with a
change in thyroid hormone levels can help reduce the incidence of possible adverse health effects
with exposure to parabens.

Methodology: The selected study variables were analyzed using SAS version 9.2. Data were
obtained from the 2007-2008 National Health and Nutrition Examination Survey (NHANES).
Analyses were performed separately for adolescent females (12-19) and adult females (20+).
Weighted means were performed for the main independent and dependent variables of interest
stratified by race/ethnicity groups and by smoking status. Independent samples t-test and ANOVA
was used to test significance of differences of weighted means. Weighted bivariate linear regression
was performed for each dependent variable (Thyroid Stimulating Hormone [TSH], Triiodothyronine
[T3], and Thyroxine [T4]) regressed on butylparaben. Weighted multiple linear regressions were
performed and parameter estimates with 95% confidence intervals were used to ascertain the
measure of effect. Separate regression models stratified by age group (adolescent vs. adult) were ran
for each dependent variable (TSH, T3, and T4) regressed on butylparaben level and covariates,
race/ethnicity and smoking status (ever smoked).

Results: Weighted bivariate linear regression showed that among adult females, for each ng/ml
increase in butylparaben, there was a -1.07 decrease in ng/dL T3 (p<. 05) levels. Among adult
females, for each ng/ml increase in butylparaben was associated with a -0.12 decrease in ug/dL T4
(p<. 01) levels. Butylparaben was not predictive of TSH (p=. 15), T3 (p=. 79), or T4 (p=. 07) levels
in adolescent females, whereas butylparaben in adult females was not predictive of TSH (p=. 55)
levels.
Weighted multiple linear regression showed higher butylparaben levels among adult females were
associated with 0.12 ug/dL lower than average T4 levels (p<. 01) controlling for race/ethnicity and
smoking status; however, no association was found among adolescent females. Mexican American
adult females had 0.17mIU/L lower than average TSH levels compared to other race adult females
(p<. 001), whereas, other Hispanic adolescent females had 0.3 mIU/L higher than normal TSH levels
compared to other race adolescent females (p<. 05) and other Hispanic adult females had 0.12mIU/L
higher TSH levels compared to other race adult females (p<. 05), controlling for butylparaben and
smoking status. Other Hispanic adult females showed 0.03 ng/dL lower than average T3 levels
compared to other race adult females (p<. 05) whereas other Hispanic adolescent females showed
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0.67 ug/dL lower than average T4 levels compared to other race adolescent females (p<. 0001),
controlling for butylparaben and smoking status. Non-Hispanic Black female adolescents had 0.44
ug/dL higher than average T4 levels compared to other race adolescent females (p<. 05) whereas
non-Hispanic black adults showed a 0.28 ug/dL higher than average T4 levels compared to other
race adult females (p=. 05), controlling for butylparaben and smoking status. Ever smoking status
was not associated with any of the thyroid hormone measures.

Conclusion: While parabens are currently not considered endocrine disruptors, the human
metabolism of and effects from exposure to parabens are not well understood. Results from this
study showing decreased levels of some thyroid hormone levels (TSH, T3, and T4) associated with
increased levels of butylparaben was found, as well as differences in thyroid hormone levels among
racial/ethnic groups. Although not many human studies have found significant results, 10 some
rodent studies have found butylparaben associations with thyroid hormone changes.4, 6, 19, 54 The
results of this study indicating no statistically significant association between butylparaben and
decreases in thyroid hormone levels are consistent with results of some rodent studies.7, 8, 54, 55 In
light of these findings, additional human studies with paraben exposure and thyroid hormone levels
are needed to increase knowledge of the mechanism and effect of parabens in the human body.

Key Words: Butylparaben, Thyroid Stimulating Hormone (TSH), Triiodothyronine (T3),
Thyroxine (T4), NHANES, Female, Cross-sectional, Ever Smoking, Race/Ethnicity.

	
  viii	
  

Table of Contents
Abstract……………………………………………………………………………………….……6-7
List of Tables and Figures……………………………………………………………………………10
Chapter I Introduction
1a. Background…………………………………………………..…………………………………..11
1b. Purpose of Study……………………………………………………………………...………11-12
1c. Hypothesis………………………………………………………………………………………..12
Chapter II Literature Review
2a. Overview of Parabens……………………………………………………………………..……..13
2b. Legislations of Parabens…………………………………………………………………...…13-14
2c. Exposure to Parabens…………………………………………………………………………….14
2d. Metabolism of Parabens in Humans……………………………………...…………………..15-16
2e. Endocrine System…………………………………………………………………………….16-17
2f. Triiodothyronine (T3)……………………………………………………………………………17
2g. Thyroxine (T4)…………………………………………………………………………………..17
2h. Thyroid-Stimulating Hormone (TSH)…………………………………………………………...17
2i. Endocrine Disruption…………………………………………………………………….……18-19
2j. Estrogenic Effects of Parabens………………………………………………………………..19-20
2k. Smoking………………………………………………………………………………………….20
Chapter III Methodology
3a. Data Source………………………………………………………………………………………21
3b. Study Population……………………………………………………………………………..21-22
3c. Data Analysis…………………………………………………………………………………….23

	
   ix	
  

Chapter IV Results
4a. Sample Demographics…………………………………………………………………………...24
4b. Descriptive Statistics…………………………………………………………………………25-28
4c. Bivariate Analysis…………………………………………………………………………….28-29
4d. Multivariate Analysis…………………………………………………………………….......29-32
Chapter V Discussion and Conclusion
5a.
Discussion……………………………………………………………………………….………..33-34
5b. Strengths…………………………………………………………………………………………35
5c. Limitations……………………………………………………………………………………….35
5d. Future Study………………………………………………………………………………….35-36
5e. Conclusion………………………………………………………………………………………..36
References………………………………………………………………………………………..37-41
Appendices…………………………………………………………………………………...….42-44

	
   x	
  

List of Tables and Figures
Figure 1: Basic Paraben Chemical Structure………………………………………………………….3
Figure 2: Butylparaben Chemical Structure…………………………………………………………..3
Figure 3: Parabens Exposure and Metabolism Pathways……………………………………………..6
Figure 4: Release and Flow of TSH, T3, and T4 Hormones.
Adapted from Faix & Thienpont 2013………………………………………………………………...8
Figure 5: Inclusion and Exclusion Subsample Flow Chart…………………………………………..12
Table 1: Distribution of Race/Ethnicity in Adolescent and Adult Females………………………….14
Table 2: Distribution of Race/Ethnicity in Butylparaben and Thyroid Hormone
Subgroups Among Adolescent and Adult Females………………………………………………….14
Table 3: Weighted Means of Butylparaben, TSH, T3, and T4 for Adolescent
and Adult Females by Race/Ethnicity Groups……………………………………………………….15
Table 4: Weighted Means of Butylparaben, TSH, T3, and T4 for Adolescent
and Adults Female Smokers and Non-Smokers……………………………………………………..16
Table 5: Weighted Regression of TSH, T3, and T4 on Butylparaben for
Adolescent and Adult Females………………………………………………………………………16
Table 6: Weighted Regression of TSH (log mIU/L) on Butylparaben (log ng/ml)
and Covariates……………………………………………………………………………………….17
Table 7: Weighted Regression of T3 (ng/dL) on Butylparaben (log ng/ml)
and Covariates………………………………………………………………………………………..18
Table 8: Weighted Regression of T4 (ug/dL) on Butylparaben (log ng/ml)
and Covariates………………………………………………………………………………………..19
Appendices:
Table 9: Parabens and Synonymous Names…………………………………………………………29
Table 10: Trimester Specific T3, T4, and TSH Hormone Ranged During Pregnancy………………30
Table 11: Butylparaben Studies with Estrogenic Results……………………………………………31

	
   xi	
  

Chapter I
Introduction
1a. Background
Parabens, widely used for their antibacterial properties, are found in many personal care products.
Parabens are an ester of parahydroxybenzoic acid. It is believed that the pharmaceutical industry first
used parabens as preservatives in the 1920s. Over the decades since its introduction, parabens have
found their way into many products used daily such as cosmetics, hair products, lotions, shaving
products, etc. Parabens are sometimes used in food and drink products, especially canned goods, to
help preserve the product and create a longer shelf life.
Starting in the early 1990s the fear of possible endocrine disrupting powers of parabens began, due
to articles suggesting negative health effects from pesticides and other man-made chemicals.1-4 In
vivo and in vitro studies soon followed; an overview of these studies will be covered in the literature
review. To date, it is uncertain whether or not parabens cause endocrine disruption in humans. Many
rodent studies have shown estrogenic tendencies, whereas some others have shown small to no
estrogenic effect. 5-9 Few human paraben studies have been completed, 10-12 also with conflicting
results.
A small number of natural or chemical compounds have been scientifically proven to create
endocrine disruption including, diethylstilbesterol (DES), dioxin, polychlorinated biphenyls (PCBs),
DDT, and some other pesticides. 13 Endocrine disruption causes interference with the normal
functioning of the endocrine system. Thyroid hormones, which control many bodily functions
including growth, development, and reproduction, are very important to human homeostasis.
Thyroid hormones are also incredibly important for fetus and child development, without which
could cause detrimental developmental effects. The long-term, low-dose effect of paraben exposure
is not known, nor has it been studied, thus the risk for negative human health effects is unknown.14

1b. Purpose of Study
The purpose of this study was to examine the association between butylparaben exposure and
thyroid function in females age 12 and over, in a nationally representative, human population. This
topic is important to public health because of the everyday use of products that contain parabens
such as cosmetics and foods. Past studies have shown parabens associated with breast cancer as well
as damage to sperm cells. The Cosmetic Ingredient Review Expert Panel (CIR) concluded that
parabens are safe as cosmetic ingredients. However the anti-paraben movement has recently led
many cosmetic companies to remove parabens from their products. Overall, increasing the
knowledge of the scientific community on the possible harmful effects of parabens is the main
objective of my study. In order to more fully examine the role of parabens in relation to thyroid
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levels this study aims to use a nationally representative dataset to show the association of urine
paraben levels with blood thyroid levels.

1c. Hypothesis
H1: Butylparaben will be associated with decreases in thyroid hormone levels (TSH, T3, and T4).
H0: Butylparaben will not be associated with decreases in thyroid hormone levels (TSH, T3, and
T4).
This study examined the research question of whether butylparaben levels in urine was associated
with blood thyroid hormone levels (TSH, T3, and T4) in females aged 12 and over in the National
Health and Nutrition Survey from 2007-2008. Specifically, the central hypothesis of this study is that
butylparaben will cause thyroid hormone levels to decrease. Previous studies showed that analyzing
data among two separate age groups, adolescents aged 12-19 and adults age 20 and over, was
warranted due to differing thyroid activity among age groups.10 The results of some studies suggest
that parabens might be thyroid hormone receptor agonists.15, 16 Ever smoking and race/ethnicity were
controlled for in the analyses; women who were pregnant, taking birth control, and who had thyroid
problems were excluded from the study due to differing levels of thyroid hormones caused by each
factor. Race/ethnicity was adjusted for when estimating the association between butylparaben and
thyroid hormone levels.

2	
  

Chapter II
Literature Review
The literature review contains compiled research from various studies on paraben exposure and
thyroid levels as well as the estrogenic and endocrine disrupting effects of parabens. This review
also is composed of an overview of parabens, the endocrine system, and thyroid hormones. The
literature review is designed to help understand parabens, how they work, and what effects they have
on human health.

2a. Overview of Parabens
Parabens are man-made chemicals that are considered esters of p-hydroxybenzoic acid. Parabens are
one of the most commonly used preservatives in personal care products, foods, beverages, and
pharmaceuticals. Parabens are readily used throughout the world due to their low cost and low
toxicity. Methylparaben, propylparaben, and butylparaben are the most frequently used in personal
care products. The use of more than one paraben or similar preservative within a product is common
practice. With the use of multiple preservatives smaller doses can be used while increasing the
preservative effect. Preservatives, such as
Figure 1: Basic
Figure 2: Butylparaben
parabens, are used in products to prevent
Paraben Structure
Structure17	
  
growth of microbials and to maintain the
C11H14O3
integrity of the product. The first usage of
	
  
parabens date back to 1920 when the
	
  
pharmaceutical industry used them as
	
  
	
  
preservatives.10 The chemical structures of
a basic paraben as well as butylparaben,
the main paraben of interest for this study,
are shown in Figures 1 and 2.

2b. Legislation of Parabens
In the United States, parabens are not widely legislated. The Food and Drug Administration (FDA)
does not regulate ingredients in cosmetics, where a majority of parabens can be found. Color
additives are the only ingredient that may be regulated by the FDA under The Federal Food, Drug,
and Cosmetic Act (FD&C Act). 18 In comparison, many other countries, including the European
Union (EU) countries and Japan, have limits on the amount by mass of parabens allowed in cosmetic
products: 0.4% for a single paraben and 0.8% for multiple parabens in EU countries, and 1.0% total
paraben concentration in Japan.19 Increasing concern about endocrine disruption from man-made
chemicals has lead to a review of the toxicity of parabens. The Cosmetic Ingredient Review expert
panel examined the safety assessment of parabens in 2008. After reviewing hundreds of references
on parabens the panel concluded that parabens are safe to use. The panel set no-observed adverse
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effect levels (NOAEL’s) at 1.2mg/kg bw/day for adults and 0.3mg/kg bw/day for infants.20 In the
European Union the Scientific Committee on Consumer Products (SCCP) concluded that
methylparaben and ethylparaben are safe for use in cosmetics at up to 0.4% of the cosmetic
concentration, with an acceptable daily intake (ADI) set at 10mg/kg/bw/day.20 Insufficient results
were found for propyl-, isopropyl-, butyl-, and isobutylparaben, with no ADI set for these parabens.
Butylparaben is not safe to be used in food products according to data collected by the WHO.21, 22
Examining the regulation that other countries have placed on parabens in comparison to the United
States, there is a need for product review programs to regulate parabens being used for human
consumption. A sign of hope for paraben regulation is the formation of the United States Endocrine
Disruptor Screening and Testing Advisory Committee (EDSTAC).23

2c. Exposure to Parabens
The most common exposure to parabens is through personal care products including but not limited
to: makeup, moisturizers, hair-care products, shaving creams, pharmaceuticals, foods, drinks. A
1995 study by Rastogi et al. analyzed 215 cosmetic products and found that 77% of rinse-off
products contained parabens, while 99% of leave-on products contained parabens.24 Dodson et al.
completed a study which tested 213 products for parabens; parabens were found in 10 products, 7 of
which were from products where parabens were not found on the label.25 A study done by Rastogi
found that 45% of skin creams were incorrectly labeled, while 10% of other products were
mislabeled with respect to parabens.26 Retail cosmetics must declare ingredients on the packaging of
the product, which helps to determine which products contain parabens. In Appendix 1 is a list of
names used for each paraben.
Humans are exposed to parabens via three routes: dermal, inhalation, and ingestion. The majority of
personal care products enter the body through dermal exposure. While food and drink are the main
sources of ingestion and air (and dust) is the main route for inhalation exposure, presumably from
personal care product usage.27, 28 The amount of parabens found in indoor air and dust vary
regionally, most likely due to differing consumption of paraben containing personal care products.27
Parabens have also been found in ground water as well as waste water treatment facilities, most
likely caused by run-off from daily usage of parabens.29 Daily estimates of paraben usage from
cosmetic products for adults is 17.76g and 0.378g for infants, calculated by Błędzka, et al. from
Cosmetic Ingredient Review panel estimates.19 The U.S. Food and Drug Administration’s Center for
Food Safety and Applied Nutrition has estimated a consumption rate of 37 ng/day for
butylparaben.30 Differences in daily exposure may be due to environmental factors.31 Environmental
factors could include differences in climate, socioeconomic, cultrual, or demographic factors. These
factors can change the amount of paraben containing products used. It has been found that women
have higher rates of parabens found in their blood, most likely due to the amount of paraben
containing perosnal care products used daily.11 Exposure to parabens for pregnant women is of
special concern due to the possible negative effects to the unborn child.32
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2d. Metabolism of Parabens in Humans
Metabolism of parabens in the human body depends on the route of exposure. After oral exposure,
the parabens travel to the gastrointestinal tract and blood where they are rapidly absorbed. It is
thought that parabens are broken down by esterase, leading to hydrolysis; p-hydroxybenzoic acid
(PHBA) is the main product that results from hydrolysis of parabens.33 The metabolized parabens
are then excreted in urine and feces. The body excretes a majority of orally ingested parabens within
the twenty-four hours following exposure.19 Dermal exposure also results in absorption into the
blood stream and metabolism by esterase. Increased chain length of the paraben decreases the ability
of the paraben to penetrate the skin.20 However, the metabolic rate of parabens is based on the
amount of paraben that penetrates the skin; for example, butylparaben is hydrolysed at a higher rate
when compared to propylparaben.34 Oral and dermal exposures both lead to absorption in the blood
as well as the liver. In the liver the parabens are adjoined with glycine, sulfate, or glucuruonate,
which aids in the breakdown of parabens for excretion in the urine.35 Parabens also have lipophilic
characteristics that cause them to be absorbed and remain intact in human tissue. According to
Aubert et al. results of a study on lab rats showed that 50% of dermally applied paraben was
absorbed.36 The presence of intact parabens found in human excretions shows that they have escaped
either skin or intestinal/liver metabolism.37
Continuous dermal exposure to parabens may result in bioaccumulation according to a study by
Ishiwatari et al.38 It has been shown that hydrolysis of parabens occurs more slowly in dermal
exposure compared to exposure to the liver by route of ingestion.39 The slowed hydrolysis of
dermally exposed parabens may be the reason for accumulation in the body. In comparison to oral
and dermal absorption of parabens in the body, subcutaneous exposure creates a large exposure to
parabens in the body due to the bypassing of hydrolysis in skin and gastrointestinal system.40 Figure
3, shows the different human exposure to parabens and how they are metabolized in the body.
Human metabolism data are lacking, particularly showing the fraction of excreted paraben versus the
fraction of excreted p-hydroxybenzoic acid; which would aid understanding the differences in
metabolism by exposure route.41 However, it is known that most of a paraben is excreted in a
conjugated form, with some amount of parabens being excreted in the free form.42
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Figure 3: Exposure and Metabolism Pathways of Parabens
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2e. Endocrine System
The endocrine system controls many human bodily functions. The endocrine system produces
hormones at various glands located in the body. The hormones then travel all over the body to
maintain organs and tissues. The glands that release the hormones act as messengers to the receptors
that collect and respond to the hormones. Reproduction, growth, sexual development, energy levels,
bone and muscle strength, and homeostasis are some, but not all, of the areas that are governed by
the endocrine system.43 The endocrine system has ten glands including: adrenal, hypothalamus,
ovaries, pancreas, parathyroid, pineal, pituitary, testes, thymus, and thyroid gland.44 Hormones
created in the endocrine system must find a compatible receptor in order to bind and carryout the
instructions of the hormone.45 Hormones in reaction to a receptor can do one of two things, either
alter an existing protein or turn on a gene to create a new protein. The main hormones of interest for
this study were thyroid-stimulating hormone (TSH), Triiodothyronine (T3), and thyroxine (T4). In
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the human body, the pituitary gland creates thyroid-stimulating hormone (TSH), among other
hormones, while T3 and T4 are created by the thyroid gland.

2f. Triiodothyronine (T3)
Triiodothyronine or T3 is created from a conversion of T4 in the blood. The lifespan of T3 is shorter
than the lifespan of T4 to help ensure that T4 creates a steady flow of T3 in the body. The reference
values of T3 are 80-190 ng/dL for those aged one or older.46 High levels of T3 can create rapid heart
rate, insomnia, anxiety, as well as harm to the bones.47 For adults and children, T3 values greater
than 180 ng/dL and greater than 200 ng/dL, respectively, are signs of hyperthyroidism.
Hyperthyroidism should not be diagnosed using only a T3 test result, but a thyroid panel instead.
Lower than average T3 levels could be due to a long-term illness, hypothyroidism, or starvation.

2g. Thyroxine (T4)
Thyroxine or T4 is created by the thyroid gland of the endocrine system. T4 tests are usually done on
patients that may have hyper- or hypothyroidism or infertility problems. Some things may cause T4
levels to increase including, birth control, estrogens, methadone, tamoxifene, steroids, androgens,
barbiturates, and lithium. A normal range of T4 is 4.5-11.2 mcg/dL.48 Results that are below the
normal range could be caused by many things, including hypothyroidism, long term illness, or
malnutrition.

2h. Thyroid-Stimulating Hormone (TSH)
Thyroid-stimulating hormone also known as thyrotropin, is created by the pituitary gland, which is
then sent to the thyroid gland in order to create T4 and T3. As shown in Figure 4, the pattern of
release and flow for TSH, T3, and T4 is shown throughout the endocrine system. TSH is released in
a diurnal pattern, which means that it is released daily with it active mainly in the daytime.49 The
normal reference range for TSH usually depends on the health professional, but this study will use
the American Association of Clinical Endocrinologists range of 0.2-3.0 mIU/L.50 TSH values below
the normal range could be due to hyperthyroidism, Graves’ disease, goiter, pituitary damage, or
taking thyroid medication. It is important to note that the normal range for thyroid test results for
pregnant women should follow trimester specific ranges (shown in Table 2).

	
   7	
  

Figure 4: Release and Flow of TSH, T3, and T4 Hormones
Adapted from Faix & Thienpont 2013.49

TSH	
  

2i. Endocrine Disruption
Endocrine disruption occurs when a body is exposed to a chemical, either natural or man-made,
which in turn causes interference with the body’s normal endocrine system functioning, producing
adverse effects.51 Chemicals that disrupt the endocrine system are called, endocrine-disrupting
compounds (EDC). 52 It is important to note that some endocrine disruptors may be naturally present
in food as phytoestrogens.23 There are many definitions of endocrine-disrupting compounds.
The EPA has defined EDC as, …exogenous agents that interfere with the production,
release, transport, metabolism, binding, action, or elimination of the natural hormones in the
body responsible for the maintenance of homeostasis and the regulation of developmental
processes.53
Estrogens, either natural or chemically derived, are known to increase T4-binding globulin (TBG),
which in turn increases total T4 concentrations.12 This increase of T4 is thought to make the
endocrine system unstable, which may lead to endocrine disruption. Endocrine disruption can occur
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one of four ways. First, the chemical can simulate a hormone, which confuses the body into overresponding to the stimulus. Second, the chemical can imitate the hormone and cause it to respond at
incorrect times. Third, the chemical can block the receptors of a hormone. Finally, the chemical can
over or under produce hormones to stimulate or hinder the system. Endocrine disruptors are thought
to be able to bind to the estrogen receptor, which would affect the estrogen-dependent genes.5
Another option is that parabens are similar structurally to xenobiotics, thus the estrogenicity of
parabens may be a result of suppression of estrogen sulfotransferases (SULTs). 54 Taxvig et al,
believes that parabens interfere with the transport of cholesterol to the mitochondria, which would
thereby interfere with steroidogenisis.15
It is important to note that some pharmaceuticals purposely create endocrine disrupting effects, such
as birth control pills. Following the passing of the Food Quality Protection Act and the Safe
Drinking Water Act in 1996, the EPA began screening chemicals for endocrine disruption
capabilities under the Endocrine Disruptor Screening Program (EDSP). 55 A lack of regulation for
parabens and other potential endocrine disrupting compounds has led to many in vivo and in vitro
studies to examine the estrogenic effects of parabens (see table 3 in appendices).

2j. Estrogenic Effects of Parabens
It has been theorized that butylparaben possesses weak estrogenic effects when exposed
subcutaneously, while another study found negative fertility effects from oral exposure to butyl- and
propylparaben.5, 7 When the latter study was repeated with a larger study design, no effect was
found.8, 9 Another rodent development study found that butylparaben did not affect development of
rodent fetuses in any aspect, which led to the finding that butylparaben does not have a strong
estrogenic effect on development.56 Some may argue that the estrogenic effects found in rodent
studies cannot be extrapolated to humans.57 A study conducted on humans, dermally exposed 2.0%
butylparaben on the whole body for two weeks did not have a reproductive effect.12 Another
important study using fertility clinic data showed no evidence for a relationship between methyl-,
propyl-, or butylparaben and altered hormone levels or sperm quality; however, it was found that
butylparaben has greater reproductive toxicity potential.11 A nationally representative data study
showed ethyl- and butylparaben to decrease thyroid hormone levels in females but not males.10
It is thought that disease of the thyroid gland is related to breast cancer, however this has not been
proven. Some studies have found parabens in breast cancer tissue 14, 58 and try to link parabens to
breast cancer. However, there is no scientific basis for hypothesizing that parabens are linked to the
development of breast cancer.59 Over recent decades an increase of breast cancer incidence has been
correlated with the growth of personal care product use in the Western world, however it is
important to note that other lifestyle changes have occurred during this time that could possibly
confound correlation results.14 Another difficulty in establishing causation of parabens is that the
harm or adverse effects may not come until many years after exposure.60
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Table 3 in the appendices, shows the various studies that have shown estrogenic effects from
butylparaben, adapted from P.W. Harvey and D.J. Everett.61 According to Scialli, A. (2011) the
studies each have limitations that make them unsupported, outlined in his paper.40 While the debate
of the estrogenic effects of parabens continues, some people have disputed the possible additive or
synergistic effect of multiple weak estrogenic compounds.62 However it has been found that
compounds that are considered reproductive toxins have an adversity threshold, which would limit
the additive or synergistic effects of multiple parabens.63 The long-term effects of low-level paraben
exposure on the human body have not been studied and therefore are unknown.58 A need for further
research on paraben human exposure is important to further understand paraben potency.

2k. Smoking
Smoking cigarettes has been shown to have a weak stimulatory effect on thyroid function and size.64
Although the mechanism is unknown, it is thought that the nicotine included in tobacco products
causes a stimulatory effect of the nervous system, which in turn increases thyroid secretion.65 Some
studies have found TSH levels are lower in those who are smokers.66-68 Various studies have shown
differing results for specific thyroid levels. For thyroxine (T4), cigarette smoking was shown to
slightly elevate T4 levels 69, 70 or create no change in T4 levels.65, 71, 72 For Triiodothyronine (T4),
cigarette smoking was shown to increase T3 levels 73, 74 or create no change in T3 levels. 71, 72
Cigarette smoking was shown to decrease TSH levels 70, 73 or remain unaltered. 66, 75 It is important
to note that my study looked at ever smoked data instead of current smoking data.
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Chapter III
Methodology
3a. Data Source
Data used in these analyses were collected from the 2007-2008 National Health and Nutrition
Examination Survey (NHANES).76 NHANES is conducted by the Center for Disease Control and
Prevention (CDC) as an ongoing, cross-sectional study on the health and nutrition of adults and
children in the United States. Participants of NHANES are selected by stratified multistage
probability sampling of the civilian non-institutionalized population of the United States.77 The first
stage of the multistage probability sampling of NHANES began with primary sampling units
(PSUs), which were usually counties or small groups of adjacent counties. The PSUs were selected
with probabilities proportionate to size. During the second stage, blocks or groups of blocks were
selected within the PSUs. For the third stage, selections of dwelling units within the census blocks
were chosen. During the fourth and final stage, a group of individuals were chosen from the sampled
households to complete the household interview.78 Survey information was collected through
household interviews by trained interviewers. Physical examinations, laboratory tests, and other
measurements were completed in mobile examination centers.

3b. Study Population
Of the 10,149 participants of the 2007-2008 NHANES data collection, 2,718 participants were
chosen to be included in the one-third subsample of paraben testing. This subsample included 114
participants with missing butylparaben data. Analyses were restricted to females 12 and over who
were not pregnant, not taking birth control, and did not have thyroid problems, totaling to 897
participants. A total of 957 men, 622 females under 12 years of age, 64 women taking birth control,
20 pregnant women, 158 women with thyroid problems, and 6 with outlying values were excluded.
Figure 5 goes into more detail for inclusion and exclusion criteria in a flow chart.
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Figure 5. Inclusion and Exclusion Subsample Flow Chart
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3c. Butylparaben and Serum Thyroid Measures
Butylparaben and serum thyroid measures were measured in a one-third subsample of the dataset.
Subsamples were done to prevent participant burnout. Mobile examination centers were used to
collect examination and laboratory data. Butylparaben measures were collected from participants 6
and over using spot urine samples that were stored at -20°C until analysis. Hydrolysis of the
conjugated specimen using β-glucuronidase/sulfatase, was followed by solid phase extraction (SPE),
reverse-phase high-performance liquid chromatography separation, and atmospheric pressure
chemical ionization-isotope dilution and tandem mass spectrometry (MS/MS). These measure
methods are more fully described in a previous study.42 The limit of detection (LOD) for
butylparaben was 0.2 ug/L. Serum thyroid measures were collected from participants 12 years and
over from the NHANES thyroid profile. The serum samples were measured with immunoenzymatic
assays.

3d. Data Analysis Overview
Data analyses were performed using SAS software (version 9.2; SAS Institute, Cary, NC). SAS
survey procedures were employed to account for the complex, multistage study design of
NHANES.79 Results presented are weighted except where noted otherwise. Descriptive statistics
were obtained to summarize the distribution of study variables. Butylparaben and TSH were nonnormally distributed for both the adolescent and adult age groups and was log transformed.
Concentrations of butylparaben that were below the LOD (limit of detection) were replaced in the
NHANES dataset with values equal to the LOD divided by the square root of two. Weighted means
were obtained for the main independent and dependent variables of interest stratified by
race/ethnicity group and by smoking status. Independent samples t-test and ANOVA was used to test
whether butylparaben, TSH, T3, or T4 levels differed across race or smoking status groups.
Weighted bivariate linear regression was performed for each independent variable with the
dependent variable. Weighted multiple linear regressions were performed and parameter estimates
with 95% confidence intervals were used to ascertain the relative measure of effect. Separate
regression models stratified by age group were ran for each dependent variable (TSH, T3, and T4)
regressed on butylparaben level and covariates, race and smoking status. An alpha=0.05 was used to
determine statistical significance.
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Chapter IV
Results
4a. Sample Demographics
The sample of females 12 years old and over totaled to 891 participants after exclusionary criteria
were applied. Thirty-three adolescents (12-19 years old) were omitted from the analytic sample due
to missing data on the variables, while 58 adults (20+ years old) were excluded due to missing
values. The final study analytic data consisted of 800 participants, with 663 in the adult (20+years
old) age group and 137 in the adolescent (12-19 years old) age group.
All analyses were done with stratified age groups and all results will be shown stratified. The
participants ranged in age from 12 to 80 with a mean age 43.79 (SD=20.29) for the total subsample.
The average age for adolescents was 15 (SD=2.14) while the average age for adults was 50
(SD=16.71). Table 4 describes the racial/ethnic distribution of adolescent and adults females.
Table 1: Distribution of Race/Ethnicity in Adolescent and Adult Female Study Subsamples
Adolescent Females N (%)

Adult Females N (%)

39 (25.83)
27 (17.88)
37 (24.50)
43 (28.48)
5 (3.31)

132 (19.91)
86 (12.97)
282 (42.53)
137 (20.66)
26 (3.92)

Mexican American
Other Hispanic
Non-Hispanic White
Non-Hispanic Black
Other Race- Including Multi-Racial
a

Unweighted Estimates of Race/Ethnicity

Table 2: Distribution of Race/Ethnicity in Butylparaben and Thyroid Hormone
Subgroups Among Adolescent and Adult Female Study Subsamples
Adolescent Females N (%)

Adult Females N (%)

170
43 (25.29)
28 (16.47)
41 (24.12)
53 (31.18)
5 (2.94)

721
139 (19.28)
88 (12.21)
294 (40.78)
171 (23.72)
29 (4.01)

137
39 (25.83)
27 (17.88)
37 (24.50)
43 (28.48)
5 (3.31)

663
132 (19.91)
86 (12.97)
282 (42.53)
137 (20.66)
26 (3.93)

Butylparaben:
Mexican American
Other Hispanic
Non-Hispanic Black
Non-Hispanic White
Other Race-Including Multi-Racial

TSH, T3, T4:

a

Mexican American
Other Hispanic
Non-Hispanic Black
Non-Hispanic White
Other Race-Including Multi-Racial
Unweighted Estimates of Race/Ethnicity
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4b. Descriptive Statistics
As shown in Table 3, weighted means concentrations of ng/ml butylparaben, mIU/L TSH, ng/dL T3,
and ug/dL T4 levels are shown with comparison between age and race. Among adolescent females,
Mexican Americans had the highest mean concentration levels of butylparaben, T3, and T4. Other
Hispanic Adolescents had the lowest mean concentration levels of butylparaben and T3. NonHispanic White adolescents had the highest mean concentration levels of TSH and the lowest mean
concentration levels of T4, whereas the other race group, which includes multi-racial races, had the
lowest mean concentration levels for TSH.
Adult female non-Hispanic Whites had the highest mean concentrations of butylparaben and TSH,
while the other race group, which includes multi-racial races, had the lowest mean concentration
levels of butylparaben and non-Hispanic Blacks had the lowest mean concentration levels of TSH.
Adult Mexican Americans had the highest mean concentration levels of T3 and T4, whereas other
race adult females, which include multi-racial races, had the lowest mean concentration levels of T3
and T4 mean levels.
The age stratified, weighted mean concentrations for TSH (mIU/L) , T3 (ng/dL), and T4 (ug/dL)
between adolescents who ever smoked and those who did not as well as adults who have smoked at
least 100 cigarettes and those who have not are presented in Table 4.

Table 3: Weighted Means of Butylparaben, TSH, T3, and T4 for Adolescent and Adult Females by
Race/Ethnicity Groups
Butylparaben
(log ng/ml)

Adolescent Females (12-19)
Mexican American
Other Hispanic
Non-Hispanic Black
Non-Hispanic White
Other Race- Including Multi-Racial

Adult Females (20+)
Mexican American
Other Hispanic
Non-Hispanic Black
Non-Hispanic White
Other Race- Including Multi-Racial

Mean (95% Confidence Interval)
TSH
T3
(log mIU/L)
(ng/dL)

T4
(ug/dL)

0.25 (0.10-0.65)
0.96 (0.14-6.43)
0.08 (0.03-0.28)
0.19 (0.05-0.65)
0.28 (0.15-0.49)
1.61 (0.14-18.2)

2.06 (1.54-2.75)
1.71 (1.20-2.43)
1.60 (0.79-3.25)
2.80 (2.15-3.63)
1.49 (1.10-2.02)
0.45 (0.06-3.31)

121.65 (117.28-126.01)
130.16 (115.28-145.04)
125.51 (116.57-134.46)
121.24 (115.48-126.99)
116.74 (111.86-121.62)
114.47 (98.14-130.79)

7.44 (7.25-7.62)
8.19 (7.65-8.74)
7.67 (7.37-7.98)
7.12 (6.93-7.31)
7.64 (7.36-7.91)
8.07 (7.50-8.65)

1.40 (0.98-2.00)
0.61 (0.30-1.24)
2.57 (1.53-4.31)
1.78 (1.01-3.13)
0.51 (0.23-1.17)
1.33 (0.16-11.2)

3.06 (2.39-3.91)
3.15 (2.29-4.33)
2.90 (1.96-4.30)
3.39 (2.52-4.57)
1.85 (1.62-2.11)
2.62 (1.06-6.47)

108.10 (105.19-111.01)
113.46 (108.01-118.91)
112.64 (107.34-117.94)
107.01 (103.06-110.97)
109.16 (104.22-114.10)
106.77 (99.62-113.95)

7.63 (7.43-7.82)
8.11 (7.81-8.41)
7.92 (7.42-8.43)
7.52 (7.25-7.78)
7.75 (7.50-8.01)
7.66 (7.24-8.08)
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Table 4: Weighted Means of Butylparaben, TSH, T3, and T4 for Adolescent and Adults Female Smokers
and Non-Smokers
	
  

Adolescent	
  Females	
  (12-‐19)	
  
Smoking	
  (Yes)	
  
Smoking	
  (No)	
  

Adult	
  Females	
  (20+)	
  
Smoking	
  (Yes)	
  
Smoking	
  (No)	
  

TSH Mean [log mIU/L]
(95% CI)

2.61
(1.41-4.82)	
  

1.95
(1.35-2.82)	
  

2.61
(1.78-3.57)	
  

3.43
(2.70-4.36)	
  

T3 Mean [ng/dL]
(95% CI)

121.77
(114.71-128.82)	
  

122.51
(116.36-128.65)	
  

110.43
(106.00-109.71)	
  

106.42
(103.13-109.71)	
  

T4 Mean [ug/dL]
(95% CI)

7.51
(7.11-7.92)	
  

7.41
(7.13-7.69)	
  

7.57
(7.39-7.75)	
  

7.67
(7.42-7.92)	
  

Butylparaben Mean [log ng/ml]
(95% CI)

0.32
(0.12-0.89)	
  

0.19
(0.09-0.44)

1.12
(0.57-2.20)	
  

1.61
(0.96-2.69)	
  

	
  
	
  
	
  
	
  
a	
  Adolescent	
  Smoking	
  question:	
  Have	
  you	
  ever	
  smoked	
  before?	
  
b	
  Adult	
  Smoking	
  question:	
  Have	
  you	
  smoked	
  at	
  least	
  100	
  cigarettes	
  in	
  lifetime?	
  

	
  
	
  

4c. Bivariate Analysis	
  
Weighted bivariate regression analysis was performed for TSH, T3, and T4 separately for adolescent
and adults females. Table 6, shows bivariate weighted regression coefficients with 95% confidence
intervals. Among adult females, a one-ng/ml increase in butylparaben was associated with a -1.07
decrease ng/dL in T3 (p<. 05). Among adult females, a one-ng/ml increase in butylparaben was
associated with a -0.12 decrease ug/dL in T4 (p<. 01). Butylparaben level was not predictive of TSH
(p=. 15), T3 (p=. 79), or T4 (p=. 07) levels in adolescent females, whereas butylparaben levels in
adult females was not predictive of TSH (p=. 55) levels.
Table 5: Weighted Regression of TSH, T3, and T4 on Butylparaben for Adolescent and Adult
Females
β (95% CI)
*Butylparaben (log ng/ml)
Adolescent Females (12-19)
TSH (log mIU/L)
T3 (ng/dL)
T4 (ug/dL)

-0.29 (-0.68-0.10)
-0.00 (-0.01-0.01)
0.24 (-0.01-0.50)

Adult Females (20+)
TSH (log mIU/L)
T3 (ng/dL)
T4 (ug/dL)

-0.05 (-0.24-0.13)
-1.05 (-2.05- -0.04)*
-0.20 (-0.30- -0.09)**

*p< .05
**p<. 01
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4d. Multivariate Analysis
Six multiple regression analyses were performed. Butylparaben was the exposure variable, and TSH,
T3, and T4 were the outcome variables, with smoking and race as controlling variables. The multiple
regression analyses were performed separately for adolescent females (12-19) and adult females
(20+). Results of the multivariate regressions stratified by age group are presented in Tables 6-8.

4d1. Thyroid Stimulating Hormone (TSH)
a. Adolescent Females (12-19 years)
TSH levels for Other Hispanic adolescent females had 0.3 mIU/L higher than the average of
all racial/ethnic groups, adjusting for butylparaben, smoking, and race (p<. 05). Butylparaben
(p=. 10) and smoking (p=. 40) were not associated with TSH level change. Mexican
American (p=. 57), non-Hispanic White (p=. 59) and non-Hispanic Black (p=. 48)
race/ethnicities were not associated with TSH level changes among adolescent females.

b. Adult Females (20+ years)
TSH levels for Mexican American adult females were 0.17mIU/L lower than the average of
all racial/ethnic groups, adjusting for butylparaben, smoking, and race (p<. 01). TSH levels
for other Hispanic adult females were 0.12mIU/L higher than the average of all racial/ethnic
groups, adjusting for butylparaben, smoking, and race (p<. 05). Butylparaben (p=. 30) and
smoking (p=. 07) were not associated with TSH level change. Non-Hispanic White (p=. 79)
and non-Hispanic Black (p=. 41) race/ethnicities were not associated with TSH level changes
among adult females.

Table 6: Weighted Regression of TSH (log mIU/L) on Butylparaben (log ng/ml) and Covariates
Independent Variables
Adolescent Females (12-19)
Adult Females (20+)
N=137
N=663
β (95%CI)

Butylparaben
Smoking
Mexican American
Other Hispanic
Non-Hispanic Black
Non-Hispanic White
F
df
R2 (adjusted R2)
p

-0.05 (-0.10-0.01)
0.14 (-0.20-0.47)
0.07 (-0.17-0.30)
0.30 (0.03-0.57)*
0.06 (-0.19-0.32)
0.09 (-0.18-0.36)

-0.01 (-0.04-0.01)
-0.14 (-0.30-0.01)
-0.17 (-0.26- -0.07)**
0.12 (0.00-0.24)*
0.02 (-0.16-0.20)
0.05 (-0.07-0.17)

7.46

7.25

6, 16
0.12 (0.11)
<. 0001*

6, 16
0.025 (0.022)
<. 0001*

*p<. 05
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4d2. Triiodothyronine (T3)
a. Adolescent Females (12-19 years)
None of the covariates in the model significantly changed T3 levels. Butylparaben
(p=. 66), smoking (p=. 83), Mexican American (p=. 12), other Hispanic (p=. 74), nonHispanic White (p=. 39), and non-Hispanic Black (p=. 83) races/ethnicities were not
associated with changes in T3 levels among adolescent females.

b. Adult Females (20+ years)
T3 levels for other Hispanic adult females were 0.03 ng/dL lower than the average of all
racial/ethnic groups, adjusting for butylparaben, smoking, and race (p<. 05). Butylparaben
(p=. 12), smoking (p=. 16), Mexican American (p=. 54), non-Hispanic White (p=. 12), and
non-Hispanic Black (p=. 16) races/ethnicities were not associated with change in T3 levels
among adult females.

Table 7: Weighted Regression of T3 (ng/dL) on Butylparaben (log ng/ml) and Covariates
Independent Variables
Adolescent Females (12-19)
Adult Females (20+)
N=137
N=663
β (95%CI)

Butylparaben
Smoking
Mexican American
Other Hispanic
Non-Hispanic Black
Non-Hispanic White
F
df
R2 (adjusted R2)
p

-0.51 (-2.88-1.86)
-1.03 (-10.99-8.94)
-6.14 (-14.15-1.88)
-1.12 (-8.08-5.84)
3.74 (-5.32-12.80)
9.49 (-10.99-8.94)

-0.01 (-0.02-0.00)
0.04 (-0.02-0.09)
-0.01 (-0.06-0.03)
-0.03 (-0.06- -0.00)*
0.03 (-0.01-0.07)
0.03 (-0.01-0.07)

2.64

8.08

6, 16
0.05 (0.03)
0.0165*

6, 16
0.028 (0.025)
<. 0001*

*p<. 05
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4d3. Thyroxine (T4)
a. Adolescent Females (12-19 years)
T4 levels for other Hispanic adolescent females were 0.67 ug/dL lower than the average of
all racial/ethnic groups, adjusting for butylparaben, smoking, and race (p<. 0001). T4 levels
for Non-Hispanic White adolescent females were 0.44 ug/dL higher than the average of all
racial/ethnic groups, adjusting for butylparaben, smoking, and race (p<. 05). Butylparaben
(p=. 18), smoking (p=. 84), Mexican American (p=. 34), and non-Hispanic Black (p=. 77)
racial/ethnic groups were not associated with change in T4 levels among adolescent females.

b. Adult Females (20+ years)
Adult female T4 levels were 0.12 ug/dL lower than average with increased butylparaben
exposure, adjusting for butylparaben, smoking, and race (p<. 01). Smoking (p=. 51),
Mexican American (p=. 47), non-Hispanic Black (p=. 05), and non-Hispanic White (p=. 40)
racial/ethnic groups were not associated with change in T4 levels among adolescent females.

Table 8: Weighted Regression of T4 (ug/dL) on Butylparaben (log ng/ml) and Covariates
Independent Variables
Adolescent Females (12-19)
Adult Females (20+)
N=137
N=663
β (95%CI)

Butylparaben
Smoking
Mexican American
Other Hispanic
Non-Hispanic Black
Non-Hispanic White
F
df
R2 (adjusted R2)
p

0.13 (-0.07-0.33)
0.07 (-0.60-0.74)
-0.14 (-0.45-0.16)
-0.67 (-0.93- -0.42)***
0.06 (-0.39-0.52)
0.44 (0.07-0.81)*

-0.12 (-0.19- -0.05)**
-0.07 (-0.29-0.15)
-0.08 (-0.30-0.14)
-0.24 (-0.50-0.02)
0.17 (-0.24-0.57)
0.28 (-0.01-0.57)

9.09

10.52

6, 16
0.15 (0.13)
<. 0001*

6, 16
0.04 (0.03)
<. 0001*

*p<. 05
**p<. 01
***p< .0001
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Chapter V
Discussion and Conclusion
In this analysis of data from 2007- 2008 NHANES exposure to butylparaben and hormone levels
(TSH, T3, and T4), bivariate results among adult females found that, butylparaben was associated
with decreases in T3 among adult females, but not associated with change in T3 among adolescent
females. Butylparaben was associated with decreases in T4 among adult females, but was not
associated with change in T4 among adolescent females. No association was found for TSH change
from increased butylparaben levels in adolescent or adult females. Multivariate results show
butylparaben associated with a decrease in T4 levels among adult females but not with adolescent
females, adjusting for race and smoking. Butylparaben was not associated with increased TSH or T3
levels for adolescent or adult females. TSH levels for Mexican American adult females were higher
than the average of all racial/ethnic groups, adjusting for butylparaben, smoking, and race. TSH
levels for other Hispanic adolescent females were higher than the average of all racial/ethnic groups,
adjusting for butylparaben, smoking, and race. T3 and T4 levels for other Hispanic adolescent
females were lower than the average of all racial/ethnic groups, adjusting for butylparaben, smoking,
and race. T4 levels for Non-Hispanic White adolescent and adult females were higher than the
average of all racial/ethnic groups, adjusting for butylparaben, smoking, and race. Smoking and nonHispanic Black race/ethnicity was not associated with changes in thyroid levels in any multivariate
model. The adolescent female group for this study showed differing results to adult females. Among
adolescent and adult females butylparaben, TSH, T3, and T4 variation was found among the race
classifications. Smoking did not present an association to any of the thyroid hormone levels in
adolescent or adult females. Though smoking did not show an association in either of the age groups,
we did find weighted mean differences for TSH, T3, T4, and butylparaben among those who smoked
and those who did not smoke as mentioned previously in the descriptive statistics section of the
results.
To the best of my knowledge, two studies have been done to which I could compare some of my
findings.10, 31 Koeppe et al. studied the association of urinary triclosan and paraben concentrations
with serum thyroid measures using the same NHANES 2007-2008. His study included both males
and females, and the use of paraben measures adjusted for creatinine in analyses. Calafat et al.
studied paraben concentrations in NHANES 2005-2006. Koeppe et al. and Calafat et al. did not
calculate geometric means of butylparaben due to high percentages of values below the LOD, while
Calafat et al. did not conduct multivariate analysis due to high percentage of values below the LOD.
10, 41
The large amount of values below the LOD in my study may have created misrepresented
means for butylparaben. The only study to which I can compare my multivariate results is from
Koeppe et al. The final regression models of Koeppe et al. included covariates, age, sex, BMI, and
urinary creatinine. My study did not examine BMI or urinary creatinine. Creatinine levels are used to
measure kidney function, and it was not clear why these measures were included in the analyses of
Koeppe et al. study. 80 Among adolescents and adults of both genders, the study found no significant

	
  20	
  

associations for T3 and T4 levels with increased levels of butylparaben. Among adolescent females
no significant associations were found for T3 and T4 levels with increased butylparaben levels.
Among adult females, evidence of an inverse association for ln-Free T3 levels with increased
butylparaben levels.10 My study used total T3 and T4, whereas, Koeppe et al. study used both free
and total T3 and T4. Lack of comparison between studies is due to differences in variables and
models used for analyses.
Hollowell et al. studied serum TSH, T4, and thyroid antibodies from 1988 to 1994 in the NHANES
III survey. This study found that TSH level among non-Hispanic blacks was lower than that of nonHispanic whites, as well as T4 levels among Mexican Americans being higher than that of nonHispanic Whites. 31 Hollowell et al. believed that environmental factors, such as, region, poverty
status, and urban versus rural residence, may have been playing a role in differences between
racial/ethnic groups.29 Differences in race/ethnic thyroid levels may also be due to the cultural
differences between race/ethnic groups, such as behaviors, beliefs, or traditions. My study also found
many race/ethnic groups associated with changes in thyroid hormone levels. It is unclear why race is
associated with changes in thyroid levels. A study by McLeod examining thyroid-related disease
among U.S. military personnel from 1997 to 2011, found thyroid levels varied across race groups.
McLeod was uncertain on whether the racial differences were caused by genetics, environmental
exposure, or a combination of both. 81 Future analyses should account for environmental factors such
as region, poverty status, SES, urban vs. rural location, as well as cultural differences.
Meeker et al. studied urinary concentrations of parabens and serum hormone levels, semen quality
parameters, and sperm damage from fertility clinic data. They found no evidence for an association
between parabens (methylparaben, propylparaben, and butylparaben) with altered hormone levels or
semen quality parameters.11 They also found that increased levels of butylparaben were associated
with sperm DNA damage. BMI of participants was associated with higher levels of parabens
concentrations, possibly due to an increase to exposure.
While few human studies have found associations for change in thyroid hormone levels from
increased levels of butylparaben10, several rodent studies have found associations for estrogenic
effects of increased butylparaben.4, 6, 19, 54 Rodent effects of butylparaben exposure included birth
defects, uterotrophic capacity, reproductive toxicity, and developmental toxicity. A list of studies
finding estrogenic effects from butylparaben exposure can be found in the appendices. A rodent
study by Daston, found no effects of butylparaben on development, while it did produce maternal
toxicity in rats at exposure doses up to 1000mg/kg/day.56 A rodent study by Hossaini et al. found a
lack of estrogenic effects from butylparaben exposure to mice.21 Conflicting results can be seen
among rodent studies, some find estrogenic effects while others find a lack of estrogenic effects. It is
important to look at if/how the rodent study results could be applied to humans. Some may argue
that the estrogenic effects found in rodent studies cannot be extrapolated to humans.57
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5a. Strengths
The use of a nationally representative study increases the generalizability of the results. To my
knowledge, this is the first study to investigate butylparaben level associated with thyroid hormone
levels (TSH, T3, T4) in a female only study design. Exclusion of pregnant women, women taking
birth control, as well as women with thyroid problems help to limit confounding effects of known
thyroid increasing properties. Stratifying analyses by age groups, adolescent’s age 12 to 19 years and
adults age 20 years and over helped to reduce bias due to differing thyroid activity in younger and
older ages.

5b. Limitations
The lack of associations in the adolescent female age group may have been due to the smaller
sample size. The adolescent female sample size was only 151 whereas the adult female sample size
was much large at 663. It is also possible that adolescents excrete lower levels of thyroid hormones
and are therefore more difficult to detect associations in thyroid levels. Among adolescent females
66 (39%) participants had butylparaben levels below the limit of detection (LOD), while adults had
256 (36%) participants with butylparaben levels below the LOD. As described in the methodology
section butylparaben levels below the LOD would be replaced with the LOD divided by the square
root of two (0.14). For both adolescent and adult females, butylparaben levels below the LOD made
up the largest percentages of values; this may have been the reason for the skewness of the
butylparaben variable. Causation cannot be established due to the use of data from NHANES, an
observational, cross-sectional study. Butylparaben was measured using a spot urine test. Parabens
are known to have a short half-life, however three recent studies show that timing of the urine spot
test do not affect the accuracy of paraben representation.41, 82, 83

5c. Future Study
It is still debated whether parabens are endocrine/thyroid disruptors. As of now, parabens are not
considered endocrine disruptors, yet some studies have shown associations of parabens with changes
in thyroid hormone levels. Studies are needed that explain the absorption and metabolism of
parabens and their effects or lack of effects on thyroid hormone levels. Previous studies researching
these topics have only been done in rodent populations (see table 3 in appendices). As mentioned
earlier multiple parabens are usually used products and thus research needs to be done to show the
effects of the combined parabens on thyroid hormone levels. Case-control studies could be used to
study the possible synergistic effects of parabens on the human body. Cohort studies would be useful
in studying the long-term effects of parabens on the human body. It is unclear why race is associated
with increases and decreases of butylparaben, TSH, T3, and T4 levels. Future study on racial effects
of parabens on thyroid hormone levels is needed to better understand the differences between races.
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A randomized controlled study (RCT) could be used to study the cause of thyroid differences in
race/ethnicities.

5d. Conclusion
In conclusion, the present analysis examined the relationship between butylparaben and thyroid
hormone levels among a female only study design using a large, representative sample of the U.S.
adolescent and adult female population. NHANES data from 814 females aged 12 and over who
were not pregnant, not taking birth control, and did not have thyroid problems increased the
generalizability of findings. I observed significant association between butylparaben and decreases
in T4 thyroid hormone levels among adult females, as well as several associations both positive and
negative between race categories and thyroid hormone levels in adolescent and adult females. While
parabens are currently not considered endocrine disruptors, the human metabolism of and affects
from exposure to parabens are not well understood. Results from this study showed decreased levels
of T4 thyroid hormone levels associated with increased levels of butylparaben, as well as differences
in thyroid hormone levels among racial/ethnic groups. The results of this study indicating no
statistically significant association between butylparaben and decreases in thyroid hormone levels
are consistent with results of some rodent studies finding a lack of estrogenic effects of parabens. 9,
20, 54
Although not many human studies have found significant results, 10 some rodent studies have
found paraben associations with adverse health effects.5, 7, 56 These results, in accordance with the in
vitro and in vivo literature, suggest that butylparaben exposure may not be associated with altered
thyroid hormone levels in humans. Additional human studies with paraben and thyroid hormone
levels are needed to confirm these potential significant findings.
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Appendices
Table 9: Parabens and Synonymous Names

Methylparaben

Ethylparaben

Propylparaben

Isopropylparaben

Butylparaben

Isobutylparaben

Benzylparaben

Benzoic Acid, 4-Hydroxy-, Methyl Ester
p-Carbomethoxyphenol
4-Hydroxybenzoic Acid, Methyl Ester
p-Methoxycarbonylphenol
Methyl-4-Hydroxybenzoate
Methyl p-hydroxybenzoate
Methyl Parahydroxybenzoate
Parahydroxybenzoate Ester
Benzoic Acid, 4-Hydroxy-, Ethyl Ester
Ethyl p-hydroxy benzoate
Ethyl 4-Hydroxybenzoate
Ethyl p-Hydroxybenzoate
Ethyl Parahydroxybenzoate
4-Hydroxybenzoic Acid, Ethyl Ester
Parahydroxybenzoate Ester
Benzoic Acid, 4-Hydroxy-, Propyl Ester
4-Hydroxybenzoic Acid, Propyl Ester
Parahydroxybenzoate Ester
Propyl p-hydroxybenzoate
Propyl p-Hydroxybenzoate
Propyl Parahydroxybenzoate
Benzoic Acid, 4-Hydroxy-, 1-Methylethyl
Ester
p-Hydroxybenzoic Acid, Isopropyl Ester
4-Hydroxybenzoic Acid, 1-Methylethyl Ester
Isopropyl p-Hydroxybenzoate
1-Methylethyl-4-Hydroxhybenzoate
Parahydroxybenzoic Acid, Isopropyl Ester
Benzoic Acid, 4-Hydroxy-, Butyl Ester
Butyl 4-Hydroxybenzoate
Butyl p-Hydroxybenzoate
Butyl p-hydroxy benzoate
Butyl Parahydroxybenzoate
Parahydroxybenzoate Ester
Benzoic Acid, 4-Hydroxy-, 2-Methylpropyl
Ester
4-Hydroxybenzoic Acid, 2-Methylpropyl
Ester
Isobutyl p-Hydroxybenzoate
Isobutyl Parahydroxybenzoate
Parahydroxybenzoic Acid, Isobutyl Ester
Benzoic Acid, 4-Hydroxy-, Phenylmethyl
Ester
Benzyl p-Hydroxybenzoate
Benzyl Parahydroxybenzoate
4-Hydroxybenzoic Acid, Benzyl Ester
Phenylmethyl 4-Hydroxybenzoate
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Table 10: Trimester Specific T3, T4, and TSH Hormone Ranges during Pregnancy

FT3 pmol/L
FT4 pmol/L
TSH mU/L

First Trimester
10-18
3.4-6.6
<0.01-3.4

Second Trimester
9-16
3.2-6.2
1.3-3.3
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Third Trimester
8-14
3.2-5.6
1.2-3.5

Table 11: Butylparaben Studies with Estrogenic Results

Butylparaben	
  

Result	
  
In	
  vivo	
  (rat	
  birth	
  defects)	
  
In	
  vitro	
  (yeast	
  C	
  receptor	
  binding)	
  
In	
  vitro	
  (human	
  MCF7)*	
  
In	
  vitro	
  (human	
  MCF7)	
  
In	
  vitro	
  (rat	
  uterus	
  receptor	
  binding)	
  
In	
  vivo	
  (rat	
  uterotrophic)	
  
In	
  vivo	
  (rat	
  uterotrophic)	
  
In	
  vivo	
  (rat	
  reproductive	
  toxicity)	
  
In	
  vivo	
  (mouse	
  reproductive	
  toxicity)	
  
In	
  vivo	
  (rat	
  development	
  and	
  reproductive	
  
toxicity)	
  
In	
  vivo	
  (rat	
  uterotrophic)	
  
In	
  vivo	
  (mouse	
  uterotrophic)	
  

*MCF7	
  is	
  a	
  hormone-‐responsive	
  breast	
  cancer	
  cell	
  line	
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